预防性全胃切除术的食欲减退。
A Decreased Appetite for Prophylactic Total Gastrectomy.
机构信息
National Cancer Institute, National Institutes of Health, Bethesda, MD.
出版信息
JCO Precis Oncol. 2024 Sep;8:e2400434. doi: 10.1200/PO-24-00434. Epub 2024 Sep 30.
Abstract
Total gastrectomy should be performed less often in germline CDH1 variant carriers based on mounting clinical evidence.
摘要
基于越来越多的临床证据，对于胚系 CDH1 变异携带者，应尽量减少全胃切除术的应用。
相似文献
1
A Decreased Appetite for Prophylactic Total Gastrectomy.预防性全胃切除术的食欲减退。
JCO Precis Oncol. 2024 Sep;8:e2400434. doi: 10.1200/PO-24-00434. Epub 2024 Sep 30.
2
Points to consider regarding prophylactic total gastrectomy in germline CDH1 variant carriers.考虑对胚系 CDH1 变异携带者行预防性全胃切除术的相关问题。
J Surg Oncol. 2024 May;129(6):1082-1088. doi: 10.1002/jso.27603. Epub 2024 Feb 22.
3
Controversies and strengths in prophylactic total gastrectomy for germline CDH1 pathogenic variant carriers.种系CDH1致病变体携带者预防性全胃切除术的争议与优势
Eur J Cancer Prev. 2023 Jul 1;32(4):308-309. doi: 10.1097/CEJ.0000000000000805. Epub 2023 Apr 7.
4
Total Gastrectomy for CDH-1 Mutation Carriers: An Institutional Experience.CDH-1 基因突变携带者全胃切除术：机构经验。
J Surg Res. 2020 Mar;247:438-444. doi: 10.1016/j.jss.2019.09.062. Epub 2019 Nov 1.
5
Hereditary diffuse CDH1 positive gastric cancer. Prophylactic gastrectomy?遗传性弥漫性CDH1阳性胃癌。预防性胃切除术？
Med Clin (Barc). 2021 Jul 9;157(1):46-48. doi: 10.1016/j.medcli.2020.04.064. Epub 2020 Aug 6.
6
Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in Mutation Carriers.遗传性弥漫型胃癌突变携带者的腹腔镜预防性全胃切除术。
J Laparoendosc Adv Surg Tech A. 2021 Jul;31(7):729-737. doi: 10.1089/lap.2021.0239. Epub 2021 Jun 7.
7
Complete histopathologic examination of risk reduction gastrectomy specimens for CDH1 germline mutation: Is it warranted in routine clinical practice?对 CDH1 种系突变的风险降低胃切除术标本进行完整的组织病理学检查：在常规临床实践中是否有必要？
Ann Diagn Pathol. 2020 Apr;45:151473. doi: 10.1016/j.anndiagpath.2020.151473. Epub 2020 Jan 20.
8
Overview on new progress of hereditary diffuse gastric cancer with variants.遗传性弥漫性胃癌伴变异的新进展概述
Tumori. 2020 Oct;106(5):346-355. doi: 10.1177/0300891620949668. Epub 2020 Aug 18.
9
Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies.CDH1 基因突变携带者行全胃切除术的适应证及微创和开放胃癌根治术的风险降低效果。
JAMA Surg. 2020 Nov 1;155(11):1050-1057. doi: 10.1001/jamasurg.2020.3356.
10
[Prophylactic gastrectomy].[预防性胃切除术]
Bull Cancer. 2025 Mar;112(3):259-262. doi: 10.1016/j.bulcan.2024.04.003. Epub 2024 May 15.
本文引用的文献
1
Germline CDH1 Variants and Lifetime Cancer Risk.胚系 CDH1 变异与终身癌症风险。
JAMA. 2024 Sep 3;332(9):722-729. doi: 10.1001/jama.2024.10852.
2
Costs of Cancer Prevention: Physical and Psychosocial Sequelae of Risk-Reducing Total Gastrectomy.癌症预防的代价：降低风险的全胃切除术后的身体和心理社会后遗症。
J Clin Oncol. 2024 Feb 1;42(4):421-430. doi: 10.1200/JCO.23.01238. Epub 2023 Oct 30.
3
Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study.遗传性弥漫型胃癌中以癌前监测替代预防性全胃切除术：一项前瞻性队列研究。
Lancet Oncol. 2023 Apr;24(4):383-391. doi: 10.1016/S1470-2045(23)00057-8.
4
Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study.采用系统随机活检进行内镜监测以早期诊断遗传性弥漫性胃癌：一项为期16年的前瞻性纵向队列研究。
Lancet Oncol. 2023 Jan;24(1):107-116. doi: 10.1016/S1470-2045(22)00700-8. Epub 2022 Dec 9.
5
Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk.CDH1 变异导致的遗传性乳腺癌与胃癌风险之间的关联。
JAMA Surg. 2022 Jan 1;157(1):18-22. doi: 10.1001/jamasurg.2021.5118.
6
Hereditary diffuse gastric cancer: updated clinical practice guidelines.遗传性弥漫型胃癌：临床实践更新指南。
Lancet Oncol. 2020 Aug;21(8):e386-e397. doi: 10.1016/S1470-2045(20)30219-9.
7
Clinical features and cancer risk in families with pathogenic variants irrespective of clinical criteria.无论是否符合临床标准，具有致病性变异的家族的临床特征和癌症风险。
J Med Genet. 2019 Dec;56(12):838-843. doi: 10.1136/jmedgenet-2019-105991. Epub 2019 Jul 11.
8
Comparison of CDH1 Penetrance Estimates in Clinically Ascertained Families vs Families Ascertained for Multiple Gastric Cancers.临床确诊家族与多例胃癌确诊家族中CDH1外显率估计值的比较。
JAMA Oncol. 2019 Sep 1;5(9):1325-1331. doi: 10.1001/jamaoncol.2019.1208.
9
Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management.无症状遗传性弥漫性胃癌患者全胃切除标本的病理特征及其对临床处理的意义。
Histopathology. 2018 Dec;73(6):878-886. doi: 10.1111/his.13715. Epub 2018 Oct 9.
10
Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.遗传性弥漫性胃癌综合征：CDH1 突变及其他。
JAMA Oncol. 2015 Apr;1(1):23-32. doi: 10.1001/jamaoncol.2014.168.
Zotero 插件